121 related articles for article (PubMed ID: 10029410)
1. A comparative analysis of allelic imbalance events in chemically induced rat mammary, colon, and bladder tumors.
Haag JD; Brasic GM; Shepel LA; Newton MA; Grubbs CJ; Lubet RA; Kelloff GJ; Gould MN
Mol Carcinog; 1999 Jan; 24(1):47-56. PubMed ID: 10029410
[TBL] [Abstract][Full Text] [Related]
2. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
Haag JD; Hsu LC; Newton MA; Gould MN
Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
[TBL] [Abstract][Full Text] [Related]
3. Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Yu M; Shan L; Snyderwine EG
Oncogene; 2003 Feb; 22(8):1253-60. PubMed ID: 12606953
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers.
Steele VE; Rao CV; Zhang Y; Patlolla J; Boring D; Kopelovich L; Juliana MM; Grubbs CJ; Lubet RA
Cancer Prev Res (Phila); 2009 Nov; 2(11):951-6. PubMed ID: 19892664
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in HCA-induced tumors.
Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutation in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder tumors and N-methyl-N-nitrosourea-induced colon tumors of rats.
Min H; Kudo E; Hino A; Yoshimoto K; Iwahana H; Itakura M; Izumi K
Cancer Lett; 1997 Jul; 117(1):81-6. PubMed ID: 9233835
[TBL] [Abstract][Full Text] [Related]
8. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM
Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235
[TBL] [Abstract][Full Text] [Related]
9. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea.
Shibata MA; Shirai T; Ogawa K; Takahashi S; Wild CP; Montesano R; Tsuda H; Ito N
Carcinogenesis; 1994 Dec; 15(12):2965-8. PubMed ID: 8001265
[TBL] [Abstract][Full Text] [Related]
11. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
[TBL] [Abstract][Full Text] [Related]
12. ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats.
Thompson TA; Haag JD; Gould MN
Carcinogenesis; 2000 Oct; 21(10):1917-22. PubMed ID: 11023551
[TBL] [Abstract][Full Text] [Related]
13. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S
Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
[TBL] [Abstract][Full Text] [Related]
14. Detection of somatic DNA alterations in azoxymethane-induced F344 rat colon tumors by random amplified polymorphic DNA analysis.
Luceri C; De Filippo C; Caderni G; Gambacciani L; Salvadori M; Giannini A; Dolara P
Carcinogenesis; 2000 Sep; 21(9):1753-6. PubMed ID: 10964108
[TBL] [Abstract][Full Text] [Related]
15. Genomic imbalance in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine.
Yu M; Ryu DY; Snyderwine EG
Mol Carcinog; 2000 Feb; 27(2):76-83. PubMed ID: 10657900
[TBL] [Abstract][Full Text] [Related]
16. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy.
Jin Z; Houle B; Mikheev AM; Cha RS; Zarbl H
Cancer Res; 1996 Nov; 56(21):4927-35. PubMed ID: 8895746
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability is infrequent in azoxymethane-induced rat intestinal tumors: An assessment by capillary electrophoresis.
Walchle C; Diwan BA; Shiao YH; Calvert RJ
Toxicol Appl Pharmacol; 1999 May; 157(1):9-15. PubMed ID: 10329502
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at chromosome 1q loci in rat mammary tumors.
Gollahon LS; Chen A; Aldaz CM
Mol Carcinog; 1995 Jan; 12(1):7-13. PubMed ID: 7818765
[TBL] [Abstract][Full Text] [Related]
19. Activation of H-ras oncogene in rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Fujita J; Ohuchi N; Ito N; Reynolds SH; Yoshida O; Nakayama H; Kitamura Y
J Natl Cancer Inst; 1988 Mar; 80(1):37-43. PubMed ID: 3276902
[TBL] [Abstract][Full Text] [Related]
20. H-ras activation and ras p21 expression in bladder tumors induced in F344/NCr rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Enomoto T; Ward JM; Perantoni AO
Carcinogenesis; 1990 Dec; 11(12):2233-8. PubMed ID: 2265474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
